Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitor-Reference-Cited by-同舟云学术

Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitor

Published:1976-09 Issue:3-4 Volume:38 Page:249-258
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J. Neural Transmission

Author:

Ludin H. P.,Bass-Verrey F.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/BF01249442.pdf

Reference15 articles.

1. Barbeau, A.: Treatment of Parkinson's disease with L-Dopa and Ro 4-4602: review and present status. Adv. Neurol.2, 173?198 (1973).

2. Bartholini, G., Pleischer, A.: Cerebral accumulation and metabolism of C14-Dopa after selective inhibition of peripheral decarboxylase. J. Pharmacol. Exp. Therap.161, 14?20 (1968).

3. Birdsong, J. H., McKinney, A. S.: Long-range motor performance changes in levodopa-treated patients with Parkinson's disease. Neurology (Minneap.)24, 107?115 (1974).

4. Birkmayer, W.: Twelve years' experience with L-Dopa treatment of Parkinson's disease. In: Current concepts in the treatment of Parkinsonism (Yahr, M. D., ed.), pp. 141?149. New York: Raven. 1974.

5. Birkmayer, W., Mentasti, M.: Weitere experimentelle Untersuchungen über den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom). Arch. Psychiat. Nervenkrh.210, 29?35 (1967).

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Cognitive Impairment in Patient with Parkinson’s Disease Treated with Levodopa;Korean Journal of Clinical Pharmacy;2018-12-31

2. A systematic review of the efficacy of globus pallidus stimulation in the treatment of Parkinson’s disease;Journal of Clinical Neuroscience;2009-07

3. Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease;Acta Neurologica Scandinavica;2009-01-29

4. Cell-based Therapeutic Approaches for Parkinson's Disease: Progress and Perspectives;Reviews in the Neurosciences;2009-01

5. Bromocriptin in der Behandlung der fortgeschrittenen Stadien des Parkinson-Syndroms;DMW - Deutsche Medizinische Wochenschrift;2008-03-26